Methyl 4-{[6-(4-bromo­phen­yl)-3-oxo-2,3,4,5-tetra­hydro­pyridazin-4-yl]methyl}benzoate
2011

Study of a New Compound with Potential Health Benefits

publication Evidence: moderate

Author Information

Author(s): Bortoluzzi Adailton J., Souza Luciana B. P., Joussef Antônio C., Meyer Emerson

Primary Institution: Departamento de Química, UFSC

Hypothesis

The study investigates the structure of methyl 4-[6-(4-bromophenyl)-3-oxo-2,3,4,5-dihydropyridazin-4-ylmethyl]benzoate as a potential candidate for antihypertensive activity.

Conclusion

The compound exhibits a unique structure that may contribute to its biological activity.

Supporting Evidence

  • The compound consists of two cyclic groups linked by a methyl­ene spacer.
  • The pyridazine ring is twisted with a dihedral angle of 17.2°.
  • Intermolecular hydrogen bonds form dimers that create a one-dimensional polymeric structure.

Takeaway

Scientists looked at a new chemical compound to see if it could help lower blood pressure. They found that it has a special structure that might be useful.

Methodology

The compound was synthesized and analyzed using X-ray crystallography.

Digital Object Identifier (DOI)

10.1107/S160053681101467X

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication